Provided by Tiger Fintech (Singapore) Pte. Ltd.

Akoya Biosciences, Inc.

1.50
+0.02001.35%
Post-market: 1.570.0700+4.67%19:03 EDT
Volume:227.31K
Turnover:341.70K
Market Cap:74.36M
PE:-1.28
High:1.78
Open:1.50
Low:1.48
Close:1.48
Loading ...

Company Profile

Company Name:
Akoya Biosciences, Inc.
Exchange:
NASDAQ
Establishment Date:
2015
Employees:
330
Office Location:
100 Campus Drive,6th Floor,Marlborough,Massachusetts,United States
Zip Code:
01752
Fax:
855 404 0061
Introduction:
Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers analysis software partnerships ecosystem; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.

Directors

Name
Position
Brian McKelligon
President and Chief Executive Officer and Director
Garry Nolan
Director
Matt Winkler
Director
Robert Shepler
Director
Thomas P. Schnettler
Director
Thomas Raffin
Director

Shareholders

Name
Position
Brian McKelligon
President and Chief Executive Officer and Director
Frederic Pla
Chief Operating Officer
Joseph Driscoll
Chief Financial Officer
Niro Ramachandran
Chief Business Officer